135 related articles for article (PubMed ID: 11792725)
1. Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats.
Soria A; Bocos C; Herrera E
J Lipid Res; 2002 Jan; 43(1):74-81. PubMed ID: 11792725
[TBL] [Abstract][Full Text] [Related]
2. Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.
Soria A; González Mdel C; Vidal H; Herrera E; Bocos C
Mol Cell Biochem; 2005 May; 273(1-2):97-107. PubMed ID: 16013444
[TBL] [Abstract][Full Text] [Related]
3. A cholesterol-rich diet causes a greater hypercholesterolemic response in pregnant than in nonpregnant rats and does not modify fetal lipoprotein profile.
Munilla MA; Herrera E
J Nutr; 1997 Nov; 127(11):2239-45. PubMed ID: 9349853
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates.
Lefebvre AM; Peinado-Onsurbe J; Leitersdorf I; Briggs MR; Paterniti JR; Fruchart JC; Fievet C; Auwerx J; Staels B
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1756-64. PubMed ID: 9327774
[TBL] [Abstract][Full Text] [Related]
5. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy.
Herrera E; Lasunción MA; Gomez-Coronado D; Aranda P; López-Luna P; Maier I
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1575-83. PubMed ID: 3287929
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.
Bijland S; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; van Klinken JB; Havekes LM; van Dijk KW; Princen HM; Rensen PC
J Biol Chem; 2010 Aug; 285(33):25168-75. PubMed ID: 20501652
[TBL] [Abstract][Full Text] [Related]
7. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
8. A sucrose-rich diet affects triglyceride metabolism differently in pregnant and nonpregnant rats and has negative effects on fetal growth.
Soria A; Chicco A; Mocchiutti N; Gutman RA; Lombardo YB; Martín-Hidalgo A; Herrera E
J Nutr; 1996 Oct; 126(10):2481-6. PubMed ID: 8857508
[TBL] [Abstract][Full Text] [Related]
9. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
[TBL] [Abstract][Full Text] [Related]
10. Differential metabolic response to 48 h food deprivation at different periods of pregnancy in the rat.
López-Soldado L; Betancor-Fernández A; Herrera E
J Physiol Biochem; 2002 Jun; 58(2):75-85. PubMed ID: 12435082
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate reduces adiposity in pregnant and virgin rats but through different mechanisms.
Gonzalez MC; Vidal H; Herrera E; Bocos C
BMB Rep; 2009 Oct; 42(10):679-84. PubMed ID: 19874714
[TBL] [Abstract][Full Text] [Related]
13. Maternal hypertriglyceridemia during late pregnancy does not affect the increase in circulating triglycerides caused by the long-term consumption of a sucrose-rich diet by rats.
Munilla MA; Herrera E
J Nutr; 2000 Dec; 130(12):2883-8. PubMed ID: 11110841
[TBL] [Abstract][Full Text] [Related]
14. Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screening.
Olivier P; Plancke MO; Marzin D; Clavey V; Sauzieres J; Fruchart JC
Atherosclerosis; 1988 Mar; 70(1-2):107-14. PubMed ID: 3162679
[TBL] [Abstract][Full Text] [Related]
15. The effects of N(4-methylphenyl)diphenimide on lipid metabolism of Sprague Dawley rats.
Hall IH; Wong OT; Simlot R; Reynolds DJ
Pharm Res; 1992 Oct; 9(10):1324-9. PubMed ID: 1448433
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice.
Jeong S; Kim M; Han M; Lee H; Ahn J; Kim M; Song YH; Shin C; Nam KH; Kim TW; Oh GT; Yoon M
Metabolism; 2004 May; 53(5):607-13. PubMed ID: 15131765
[TBL] [Abstract][Full Text] [Related]
17. Comparative responsiveness to prolonged hyperinsulinemia between adipose-tissue and mammary-gland lipoprotein lipase activities in pregnant rats.
Ramos P; Herrera E
Early Pregnancy; 1996 Mar; 2(1):29-35. PubMed ID: 9363200
[TBL] [Abstract][Full Text] [Related]
18. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
[TBL] [Abstract][Full Text] [Related]
19. Lipids and lipoproteins in maternal and fetus plasma in the rat.
Argiles J; Herrera E
Biol Neonate; 1981; 39(1-2):37-44. PubMed ID: 7213867
[TBL] [Abstract][Full Text] [Related]
20. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
